UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012372
Receipt number R000014432
Scientific Title Evaluation of the tolerability of rivastigmine patch on patients with Alzheimer's disease
Date of disclosure of the study information 2013/11/22
Last modified on 2015/12/21 10:26:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the tolerability of rivastigmine patch on patients with Alzheimer's disease

Acronym

Evaluation of the tolerability of rivastigmine patch

Scientific Title

Evaluation of the tolerability of rivastigmine patch on patients with Alzheimer's disease

Scientific Title:Acronym

Evaluation of the tolerability of rivastigmine patch

Region

Japan


Condition

Condition

Alzheimer's disease

Classification by specialty

Neurology Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The evaluation of the tolerability of rivastigmine patch on Alzheimer's disease patients who titrated at short interval to the maintenace dose

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The evaluation of the safety, tolerability and adverse event(frequency of nausea and vomit, change of dietary intake) of rivastigmine patch in patients who titrated at short interval to the maintenace dose

Key secondary outcomes

ADAS-J cog
MMSE
Medication compliance
Change of caregiver burden


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients who titrated at 1-week intervals

Interventions/Control_2

Patients who titrated at 2-week intervals

Interventions/Control_3

Patients who titrated at 4-week intervals

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients by whom the concent in the document was got.
2)Patients who are 50 to 85 years old at the assesment of baseline
3)male or female without the possibility of pregnancy
4)Patients diagnosed as dementia of the Alzheimers type by the Diagnostic and Statistical Manual of Mental Disorders 4th edition criteria
5)Patients who diagnosed as probable AD according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimers Disease and Related Disorders Association criteria
6)MMSE at baseline of patients are 23 points or less and 10 or more points
7)Patients who were able to do normally reading, writing or spearking till before the onset of dementia
8)Patients who were cooperative and able to undergo medical tests and observation by oneself or with assisit of caregiver
9)Patients who have a caregiver throughout the study. The caregiver was required to be the primary caregiver and to be willing to accept responsibility for supervising the treatment, assessing the condition of the patient throughout the study and for providing input to efficacy assessments according
to protocol requirements.

Key exclusion criteria

1)patents who have the problem of urination
2)patients who have the skin disease
3)patients who have sight and hearing handicaps and an advanced speech impediment
4)patient whom the principal investigator or subinvestigator judged to be unsuitable as an object of this research

Target sample size

144


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Shimada

Organization

Graduate School of Medicine, Osaka City University

Division name

Geriatrics and Neurology

Zip code


Address

1-4-3 Asahi-machi, Abeno-ku, Osaka city

TEL

06-6645-3889

Email

h.shimada@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Shimada

Organization

Graduate School of Medicine, Osaka City University

Division name

Geriatrics and Neurology

Zip code


Address

1-4-3 Asahi-machi, Abeno-ku, Osaka city

TEL

06-6645-3889

Homepage URL


Email

h.shimada@med.osaka-cu.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, Osaka City University

Institute

Department

Personal name



Funding Source

Organization

Graduate School of Medicine, Osaka City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 11 Month 21 Day

Last modified on

2015 Year 12 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014432


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name